LOGIN
High-Energy Focused Extracorporeal Shockwave Therapy for Preventing Glucocorticoid-Induced ONFH
December 2022
High-Energy Focused Extracorporeal Shockwave Therapy for Preventing Glucocorticoid-Induced ONFH
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1
High-energy focused extracorporeal shock wave prevents the occurrence of glucocorticoid-induced osteonecrosis of the femoral head: A prospective randomized controlled trial
J Orthop Translat. 2022 Oct 6;36: 145-151.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
One hundred and fifty-four patients receiving high-dose glucocorticoid therapy who were at risk of osteonecrosis of the femoral head were randomized to receive a single session of high-energy focused extracorporeal shockwave therapy (n=75) or control (n=79), in addition to 6 weeks of pharmaceutical intervention (alendronate sodium; Chinese herbal medicine). Outcomes of interest included Visual Ana...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Join the Conversation
Please Login or Join to leave comments.